Glutamine (GLN) and arginine (ARG) are recognized for their ability to modulate immune cell function. However, the metabolic pathways involved in their action remain unclear. It was recently shown that GLN-or ARG-enriched diets increased radical oxygen species (ROS) production by neutrophils from stressed rats. Since these two amino acids have a tied metabolism, we hypothesized that conversion between GLN and ARG (and its active metabolites NO † and polyamines) might be involved. To test this hypothesis male Sprague -Dawley rats (n 117) were randomized into thirteen groups: rats in eleven groups were rendered catabolic by dexamethasone injection (1·5 mg/kg per d for 5 d) and 6·8 mmol either GLN, ARG or non-essential amino acids (NEAA; glycine, alanine and histidine)/kg per d were given by the enteral route; one group was pair-fed to the treated groups. The regimens of all the groups were rendered isonitrogenous by the addition of NEAA. The last group was not treated and was fed ad libitum. For each supplementation three subgroups were formed, each of which received a specific inhibitor: methionine sulfoximine (inhibitor of GLN synthase; 100 mg/kg per d), S-methylthiourea (inhibitor of inducible NO † synthase (iNOS); 50 mg/kg per d) and difluoromethylornithine (inhibitor of ornithine decarboxylase (ODC); 50 mg/kg per d). Oxidative metabolism, intracellular H 2 O 2 , and extracellular O 2 †2 production were measured in unstimulated and phorbol myristate acetate-stimulated polymorphonuclear neutrophils. GLN-and ARG-enriched diets increased respiratory burst by neutrophils (oxidative metabolism of 152 (SEM 24) and 138 (SEM 45) v. 57 (SEM 18) mV for GLN-, ARG-and NEAA-enriched diets respectively, P, 0·05). In vivo inhibition of iNOS or ODC decreased ROS production induced by GLN and ARG. In vivo inhibition of GLN synthase did not modify the effect of ARG on ROS production. In conclusion, GLN and ARG modulate ROS production in neutrophils from stressed rats by the same pathway involving polyamine and NO † synthesis.
amino acids to modulate immune functions under physiological or pathological conditions. They are known to improve T-cell immmunity (Alexander, 1995; Robinson et al. 1999) , to stimulate macrophage functions (Calder & Yaqoob, 1999; Wu et al. 2000) and polymorphonuclear neutrophil (PMN) bactericidal power (Moffat et al. 1996; Furukawa et al. 1997 Furukawa et al. , 2000 Holm et al. 1999; Moinard et al. 1999) . However, the mechanisms involved in these actions are still unclear. In a recent study we showed the ability of an enterally administered diet supplemented with GLN and ARG to stimulate H 2 O 2 production by PMN. However, the mechanisms involved were not elucidated. We and others (Murphy & Newsholme, 1998) have shown that GLN may be an ARG precursor for NO † synthesis in immune cells. These data suggest that these two amino acids have a tied metabolism and so their immunomodulatory effects may be related to a common pathway. We hypothesized that GLN may act via ARG or that ARG may act through GLN neosynthesis.
The aim of the present study was therefore to determine the metabolic pathways involved in GLN and ARG action on radical oxygen species (ROS) production by PMN from stressed rats. The catabolic state was obtained by daily intraperitoneal injection of glucocorticoids (i.e. dexamethasone; DEX). This model has been demonstrated to lead to a highly reproducible catabolic state in rats, including anorexia, protein breakdown and negative N balance (Odedra et al. 1983; Ardawi & Jamal, 1990; Parry-Billings et al. 1990; Minet-Quinard et al. 2000) . In addition, glucocorticoids have immunosuppressive effects; they are responsible for changes in the distribution of leucocytes observed during stress (Shijo et al. 1998) . These changes may have a significant impact on the functioning and effectiveness of the immune response (Shijo et al. 1998) .
We evaluated the enhancing effect of GLN and ARG on respiratory burst using three different methods (chemiluminescence, flow cytometry and ferricytochrome reduction) in glucocorticoid-treated rats. We also used metabolic inhibitors in GLN-and ARG-supplemented stressed rats in order to block different metabolic pathways at the whole body level ( Fig. 1 ): methionine sulfoximine (MSO), a specific inhibitor of GLN synthase (Heeneman & Deutz, 1993) , to determine whether ARG acts through neosynthesis of GLN; S-methylthiourea (SMT), a specific inhibitor of inducible NO † synthase (Ruetten & Thiemermann, 1996) , to determine whether GLN and ARG act by a process dependent on NO † synthesis (the active metabolite of ARG); a-difluoromethylornithine (DFMO), a specific inhibitor of ornithine decarboxylase (Nsi-Emvo et al. 1996) to determine whether GLN and ARG act via polyamine synthesis (deriving from ARG).
Materials and methods

Chemicals
All chemicals were purchased from Sigma (St-QuentinFallavier, France) except for 2 0 -7 0 -dichlorofluorescin diacetate (DCFH-DA; Acros, Noisy-le-Grand, France), Plasmagel w (Belon, Neuilly-sur-Seine, France), and DEX (Soludecadron w ; Merck Sharp & Dohm, Riom, France).
Animals and study design
A total of 117 male Sprague -Dawley rats (3 months old) were used (Iffa Credo, L'Arbresle, France). After their arrival at our animal facility the rats were maintained on a standard chow diet (A04: 170 g proteins, 30 g fat, 590 g carbohydrates, and 210 g water/kg, fibre, vitamins and minerals; Usine d'Alimentation Rationnelle, Villemoisson-surOrge, France) and received water ad libitum. They were kept in individual cages in a controlled environment (constant temperature of 248C) and light cycle (lights off 8.00 -20.00 hours, lights on 20.00-8.00 hours). After this acclimatization period, the rats were randomized into thirteen groups (nine per group) as shown in Table 1 . For the next 5 d (day 0 to day 4) all the rats (except those that were pair-fed) had free access to the chow diet as described above. DEX-treated groups (i.e. groups 3 to 13, see Table 1 ) received a daily intraperitoneal injection of DEX (1·5 mg/kg per d) for 5 d (day 0 to day 4) as previously described (Minet-Quinard et al. 2000) . The pairfed group (PF) was pair-fed to DEX groups and received a daily isovolumic intraperitoneal injection of NaCl (9 g/l). The rationale for the study of a PF was the fact that DEX induces anorexia (Minet-Quinard et al. 2000) ; studying a PF thus isolates the effect of the treatment itself from the effects induced by marked anorexia. In addition to their oral chow diet the supplemented groups received enteral supplementation of GLN or ARG (6·8 mmol/kg per d) (day 0 to day 4) by oral administration as described previously (Lasnier et al. 1996) . The dose of 6·8 mmol/kg per d corresponds to 1·00 g GLN/kg per d and 2·19 g ARG/kg per d. These doses are in the range of those used in the literature (Barbul, 1995; Fürst & Stehle, 1995; Farges et al. 1999; Moinard et al. 1999) and are an extrapolation of dosages used in human subjects allowing for the high metabolic rate of rats (Cynober, 1989) . The enteral route was chosen to provide supplements, rather than mixing them with chow (Le Bricon et al. 1995) , to be certain that rats suffering from anorexia received the targeted amount of pharmaconutrients. The enteral supplementation of all the groups was rendered isonitrogenous (up to 0·5 g N/kg per d) by addition of a mixture of non-essential amino acids (NEAA; glycine, alanine, histidine in equimolar amounts). DEX-NEAA and PF groups received only the NEAA mixture (0·5 g N/kg per d) as a supplement to their regimen. In our experimental conditions, the NEAA mixture exerted neither pharmacological nor adverse effects on metabolic pathways (MinetQuinard et al. 1999) . MSO-, SMT-and DFMO-treated groups received MSO (100 mg/kg per d), SMT (50 mg/kg per d) and DFMO (50 mg/kg per d) respectively by the enteral route for 6 d (day 2 1 to day 4). The use of NEAA groups allowed us to determine whether the metabolic inhibitors are able to modify per se the parameters measured. We did not determine the effect of MSO in the GLN-supplemented group since GLN synthase is not involved in GLN catabolism. Dosages of inhibitors were selected on the basis of literature values (Nsi-Emvo et al. 1996; Ruetten & Thiemermann, 1996; Minet et al. 1997) . Concerning the effect of inhibitors per se, GLN synthase activity in muscle (extensor digitorum longus ) was determined using a colorimetric assay (Minet et al. 1997 ) and we previously demonstrated that GLN synthase activity was not detectable in muscles from MSO-treated rats (Moinard et al. 2002) . In our experimental conditions, SMT abolished NO † secretion in stimulated macrophages , which assess that SMT block NO synthase in vivo. In the case of DFMO, ornithine decarboxylase was not measured since this enzyme has a very short half-life and 24 h had elapsed since the last injection. However, it is well known that DFMO blocks ornithine decarboxylase activity in our experimental conditions (Messina et al. 1992; Morgan, 1994; Raul et al. 1995; Walters et al. 1998) .
The ad libitum group (AL) received no treatment, and was fed ad libitum.
Animal care and experimentation complied with the rules of our institution, and two of us (L.C. and M.-P.V.) are authorized by the French Ministry of Agriculture and Forestry to use this type of experimental model.
After 24 h following the last injection, rats in the NEAA, non-essential amino acids; GLN, glutamine; ARG, arginine; MSO, methionine sulfoximine; SMT, S-methylthiourea; DFMO, a-difluoromethylornithine; NaCl, intraperitoneal injection of NaCl (9 g/l) during 5 d; DEX, intraperitoneal injection of dexamethasone (1·5 mg/kg per d) during 5 d. * Amino acids were administered by the enteral route (from day 0 to day 4). All diets were made isonitrogenous (up to 0·5 g N/kg per d) by addition of a mixture of non-essential amino acids (glycine, histidine and alanine in equimolar amounts). † Metabolic inhibitor was administered by the enteral route (day 2 1 to day 4).
post-absorptive state were anaesthetized and killed by decapitation.
Blood sampling
Blood was collected on calcium heparin to isolate PMN on a gradient of Ficoll-Hypaque (for determination of oxidative metabolism and superoxide anion generation) or by sedimentation (for H 2 O 2 determination).
Procedures and analytical methods
Separation of polymorphonuclear cells for determination of superoxide anion generation. Blood was layered carefully on a double gradient of Ficoll-Hypaque (Histopaque 1083 and 1119; St Quentin Fallavier, France) with equal volumes. After centrifuging (700 g, 30 min, þ 208C), the Ficoll-Hypaque layers were removed and the PMN were transferred to a polypropylene tube (Falcon; Elvetec, Clermont Ferrand, France). The residual erythrocytes were destroyed by a short treatment with an ammonium chloride solution (ammonium chloride 16 mM, sodium hydrogen carbonate 1 mM, EDTA 0·01 mM).
The PMN were then washed twice with PBS, resuspended and adjusted to 10 6 cells/ml with Hank's balanced salt solution. Cell viability was determined by trypan blue exclusion and was more than 95 %. May-Grunwald-Giemsa staining of leucocytes was carried out to determine the efficiency of our separation, and gave more than 80 % PMN in each preparation.
Determination of oxidative metabolism by chemiluminescence assay. Oxidative metabolism was measured by chemiluminescence. Luminol-dependent chemiluminescence was measured using a luminometer (Model 1250; LKB Pharmacia, Trappes, France) with disposable polypropylene tubes at 378C. PMN (5 £ 10 5 cells) were preincubated for 5 min at 378C. Luminol was then added to the medium at a final concentration of 10 29 M. Time was recorded from the addition of the stimulating agent (phorbol myristate acetate, 10 26 M). All the results are expressed as the maximum peak values (mV) corresponding to the maximal activation state.
Determination of extracellular superoxide generation by ferricytochrome C reduction. Extracellular O 2 †2 generation was measured by reduction of ferricytochrome C (horse-heart type III) as previously described (Vasson et al. 1994) . Briefly, PMN (5 £ 10 5 cells) pre-incubated for 5 min were added to a ferricytochrome C (0·4 nM) solution and stimulated with phorbol myristate acetate (10 26 M) for 10 min at 378C. The final volume of the reaction mixture was adjusted to 0·5 ml with PBS. Incubation was stopped by placing the tubes in an ice bath for 10 min. After centrifuging (400 g, 10 min, 48C), the absorbance of the supernatant fractions was measured at 545 nm (DU540 spectrophotometer; Beckman-Coulter, Gagny, France). The amounts of extracellular O 2 †2 produced were calculated from the absorbance using an extinction coefficient of 20 nM/cm. The results are expressed in picomoles of released O 2 †2 /min per 10 6 cells. Measurement of intracellular hydrogen peroxide production by polymorphonuclear cells. Leucocytes were isolated and intracellular H 2 O 2 was measured as previously described . In brief, leucocytes were isolated after gravity sedimentation. During leucocyte oxidative burst non-fluorescent intracellular dichlorofluorescin is oxidized by H 2 O 2 to highly fluorescent 2 0 -7 0 -dichlorofluorescein. PMN were discerned among leucocyte populations and 2 0 -7 0 -dichlorofluorescein fluorescence of PMN was measured using a flow cytometer (Epics, Coulter, USA). PMN were selected on the basis of their size and granularity by the combination of low-angle forward scattered and right-angle scattered laser light. For each determination, 2500 PMN were counted.
Results are expressed as the ratio of fluorescence produced by phorbol myristate acetate-stimulated leucocytes to fluorescence produced by non-stimulated cells.
Statistical analysis
Data are expressed as mean values and SEM. Comparisons between sets of data were made using the Kruskal -Wallis H test followed by the Newman -Keuls test when appropriate as indicated in 
Results
Effect of arginine and glutamine on oxidative metabolism in stimulated polymorphonuclear cells
Oxidative metabolism evaluated by chemiluminescence was increased under GLN and ARG supplementation (DEX-GLN, DEX-ARG v. AL, PF and DEX-NEAA; P, 0·05) ( Table 2) . O 2 †2 release was increased in rats supplemented with GLN (DEX-GLN v. DEX-NEAA; P, 0·05). H 2 O 2 production by PMN from DEX-treated rats was increased (DEX-NEAA v. AL; P, 0·05). This effect was specifically due to DEX because H 2 O 2 production by PMN from PF was decreased (AL v. PF; P,0·05). Also, in another series of experiments, the same result was obtained in DEX rats in the absence of NEAA supplementation (data not shown). Supplementation with GLN and ARG further raised H 2 O 2 production by stimulated PMN (DEX-GLN, DEX-ARG v. DEX-NEAA; P, 0·05).
Oxidative metabolism in stimulated polymorphonuclear cells from rats receiving inhibitors
In the control groups (DEX-NEAA) the inhibitors used had no effect on oxidative metabolism, extracellular O 2 †2 or H 2 O 2 production by stimulated PMN (Table 3) .
In the ARG-supplemented groups, oxidative metabolism was decreased in rats treated with SMT and DFMO (DEX-ARG-SMT, DEX-ARG-DFMO v. DEX-ARG; P, 0·05). However, the three inhibitors did not significantly modify extracellular O 2 †2 generation. Concerning intracellular H 2 O 2 production by PMN, only SMT and DFMO abolished the enhancing effect of ARG (DEX-ARG-SMT, DEX-ARG-DFMO v. DEX-ARG; P, 0·05) (Table 4) .
In GLN-supplemented groups the use of SMT and DFMO abolished the GLN-induced increase in oxidative metabolism, extracellular O 2 †2 generation and intracellular H 2 O 2 production by PMN (DEX-GLN-SMT, DEX-GLN-DFMO v. DEX-GLN; P, 0·05) ( Table 5 ).
Discussion
The amino acids GLN and ARG are considered immunonutrients (De Bandt & Cynober, 1998; Calder & Yaqoob, 1999; Wu et al. 2000) . This term was introduced to describe the effects of specific nutrients on immune functions. The present study, in agreement with the literature (Moffat et al. 1996 Furukawa et al. 2000) , shows the ability of GLN and ARG to increase respiratory burst of PMN from stressed rats. GLN is utilized by immune cells. In particular, Pithon Curi et al. (1997) have already characterized the glutaminase activity in PMN. This glutaminase activity was higher than that reported for lymphocytes and macrophages, which confirms the importance of GLN for the functioning of these cells. These authors also reported that less than 1 % GLN was totally oxidized, confirming that GLN is not only a fuel for these cells but may generate other metabolites (i.e. ARG or polyamines, which may play a key role in the cells). Concerning ARG, two pathways exist in PMN. First, the arginase pathway in which ARG is converted into urea and ornithine, which generates aliphatic polyamines 
